Impaired cerebral glucose metabolism in myotonic dystrophy: A triplet-size dependent phenomenon

Neuromuscular Disorders

Volumn 8, Issue 1, 1998, Pages 39-45

  Annane, Djillali ^a,c   Fiorelli, Marco ^a   Mazoyer, Bernard ^a   Pappata, Sabina ^a   Eymard, Bruno ^d   Radvanyi, Hélène ^e   Junien, Claudine ^e   Fardeau, Michel ^d   Merlet, Pascal ^a   Gajdos, Philippe ^c   Syrota, André ^a   Sansom, Yves ^a   Duboc, Denis ^a,b  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b Hôpital Cochin ^*  (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

^d INSERM   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cerebral glucose metabolism; CTG trinucleotide repeats; Insulin resistance; Myotonic dystrophy; Positron emission tomography

Indexed keywords

COMPLEMENTARY DNA; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; PROTEIN KINASE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN BLOOD LEVEL; MALE; MYOTONIC DYSTROPHY; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ACTIVITIES OF DAILY LIVING; ADULT; BLOOD GLUCOSE; BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; PROTEIN KINASES; RADIOPHARMACEUTICALS; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED; TRINUCLEOTIDE REPEATS;

EID: 0032005627     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(97)00144-2     Document Type: Article

References (40)

1. [1] Harper P. Myotonic dystrophy: major problems in neurology, Vol. 9. Philadelphia, PA: WB Saunders, 1979.
2. [2] Harley HG, Brook JO, Rundle SA et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992;355:545-546.
3. [3] Buxton J, Shelbourne P, Davies J et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992;355:547-548.
4. [4] Brook JD, McCurrach ME, Harley HG et al. Molecular basis of myotonic dystrophy expansion of a trinucleotide (CTG) repeat at the 3′-end of a protein kinase family member. Cell 1992;68:799-808.
5. [5] Mahadevan M, Tsilfidis C, Sabourin L et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′-untranslated region of the gene. Science 1992;255:1253-1255.
6. [6] Fu YH, Pizutti A, Fenwick AG et al. An unstable triplet repeat in a gene related to myotonic dystrophy. Science 1992;255:1256-1258.
7. [7] Dunne PW, Walch ET, Epstein HF Phosphorylation reactions of recombinant human myotonic dystrophy protein kinase and their inhibition. Biochemistry 1994;33:10809-10814.
8. [8] Van der Ven PFM, Jansen G, van Kuppevelt THMSM et al. Myotonic dystrophy kinase is a component of neuromuscular junctions. Hum Mol Genet 1993;2:1889-1894.
9. [9] Whiting EJ, Waring JD, Tamal K et al. Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue. Hum Mol Genet 1995;4:1063-1072.
10. [10] Otten AD, Tapscott SJ Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc Natl Acad Sci USA 1995;92:5465-5469.
11. [11] Krahe R, Ashizawa T, Abbruzzese C et al. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 1995;28:1-14.
12. [12] Wang YH, Griffith J Expanded CTG triplet blocks from the myotonic dystrophy gene create the strongest known natural nucleosome positioning elements. Genomics 1995;25:570-573.
13. [13] Boucher CA, King SK, Carey N et al. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum Mol Genet 1995;4:1919-1925.
14. [14] Moxley RT, Corbett AJ, Minaker KL, Rowe JW Whole body insulin resistance in myotonic dystrophy. Ann Neurol 1984;15:157-162.
15. [15] Annane D, Duboc D, Mazoyer BM et al. Correlation between decreased myocardial glucose phosphorylation and the DNA mutation size in myotonic dystrophy. Circulation 1994;90:2629-2634.
16. [16] Fiorelli M, Duboc D, Mazoyer BM et al. Decreased cerebral glucose utilization in myotonic dystrophy. Neurology 1992;42:91-94.
17. [17] Milcarek C, Martincic K, Hoffman EP. Myotonic dystrophy: evidence for an RNA disorder. AFM/MDA First International Myotonic Dystrophy Consortium Conference, Paris, June 30-July 1st, 1997.
18. [18] Griggs RC, Wood DS Working Group on the Molecular Defect in Myotonic Dystrophy. Criteria for establishing the validity of genetic recombination in myotonic dystrophy. Neurology 1989;39:420-421.
19. [19] Matsui T, Hirano A. An atlas of the human brain for computerized tomography. Tokyo: Igaku-Shoin, 1978.
20. 14C-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized rat. J Neurochem 1977;28:897-916.
21. [21] Mazoyer BM, Huesman RH, Budinger T, Knittel BL Dynamic PET data analysis. J Comput Assist Tomogr 1986;10:645-653.
22. [22] Akaike H A new look at the statistical model identification. EEE Trans Automat Contr 1974;AC19:716-723.
23. 18F-2-fluoro-2-deoxyglucose: validation of method. Ann Neurol 1979;6:371-388.
24. [24] Aslanidis C, Jansen G, Amemiya C et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 1992;355:548-551.
25. [25] Pardridge WM, Boado RJ. Molecular cloning and regulation of gene expression of blood-brain barrier glucose transporter. In: Pardridge WM, editor. The blood-brain barrier: cellular and molecular biology. New York: Raven Press, 1993:395-440.
26. [26] Nagamatsu S, Kornhauser JM, Burant CF, Seino S, Mayo KE, Bell GI Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization. J Biol Chem 1992;267:467-472.
27. [27] Lund-Anderson H Transport of glucose from blood to brain. Physiol Rev 1979;59:305-352.
28. [28] Pardridge WM Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization?. Ann Neurol 1994;35:511-512.
29. [29] Baskin DG, Figlewicz DP, Woods SC, Porte D Jr, Dorsa DM Insulin in the brain. Ann Rev Physiol 1987;49:335-347.
30. [30] Hertz MM, Paulson OB Glucose transfer across the blood-brain barrier. Adv Metab Disord 1983;10:291-302.
31. [31] Namba H, Lucignani G, Nehlig A et al. Effects of insulin on hexose transport across blood-brain barrier in normoglycemia. Am J Physiol 1987;252:E299-E303.
32. [32] Clarke DW, Boyd FT, Kappy MS, Raizada MK Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain. J Biol Chem 1985;259:11672-11675.
33. [33] Clarke DW, Boyd FT, Kappy MS, Raizada MK Insulin stimulates macromolecular synthesis in cultured glial cells from rat brain. Am J Physiol 1985;249:C484-C489.
34. [34] Wozrliak M, Rydzewski B, Baker SP, Raizada MK The cellular and physiological actions of insulin in the central nervous system. Neurochem Int 1993;22:1-10.
35. [35] Moxley RT, Griggs RC, Goldblatt D Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J Clin Invest 1978;62:857-867.
36. [36] Festoff BW, Moore WV Evaluation of the insulin receptor in myotonic dystrophy. Ann Neurol 1979;6:60-65.
37. [37] Tevaarwerk GJM, Strickland KP, Lin C, Hudson AJ Studies on insulin resistance and insulin receptor binding in myotonia dystrophica. J Clin Endocrinol Metab 1979;49:216-222.
38. [38] Mably E, Strickland KP, Tevaarwerk GJM, Hudson AJ Glucose transport and oxidation in adipose tissue of patients with myotonic dystrophy. J Neurol Sci 1981;52:11-23.
39. [39] Baskin DG, Brewitt B, Davidson DA et al. Quantitative autoradiographie evidence for insulin receptors in the ehoroid plexus of the rat brain. Diabetes 1986;35:246-249.
40. [40] Thornton CA, Johnson K, Moxley RT Myotonie dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 1994;35:104-107.